– Mr. Smith brings significant experience in the successful development and commercialization of medicines for rare genetic diseases –BEDFORD, Mass. (BUSINESS WIRE) Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating prote.
Stoke Therapeutics (STOK) Appoints Ian Smith to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Stoke Therapeutics, Inc. announced the appointment of Ian Smith to its Board of Directors effective September 19. Ian F. Smith is a director of Stoke Therapeutics. He serves as a Senior Advisor to.
Ultragenyx Pharma (RARE) Appoints Amrit Ray to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.